Lightnews — Scholar-powered news

Ron Leuty @rleutybiotech.bsky.social · 4h

Genentech follows Trump lead with direct-to-patient flu drug Xofluza - San Francisco Business Times www.bizjournals.com/sanfrancisco...

Cutting out the middleman: Genentech jumps on direct-to-patient bandwagon with flu drug Xofluza - San Francisco Business Times

Cutting out the middleman: Genentech joins other major pharmaceutical companies in offering a popular flu medication directly to consumers, potentially reshaping how Americans access their prescriptio...

www.bizjournals.com

Reposted by Ron Leuty

ALS Advocacy @alsadvocacy.bsky.social · 4h

Nada for ALS

Sarah Karlin-Smith @sarahkarlin-smith.bsky.social · 5h

Here's the list --

www.fda.gov/news-events/...

2 1 1

Ron Leuty @rleutybiotech.bsky.social · 9h

Inside UCSF Health's integration of St. Francis, St. Mary's hospitals — new names new approaches
www.bizjournals.com/sanfrancisco...

UCSF Health renames Saint Francis and St. Mary's hospitals as part of $430 million integration plan - San Francisco Business Times

Things are changing for Saint Francis and St. Mary's hospitals under UCSF Health. Here’s what to expect.

www.bizjournals.com

Ron Leuty @rleutybiotech.bsky.social · 2d

The diagnosis "certainly adds jet fuel to my personal motivation tank," wrote Paulk, who was an assistant professor at UCSF before launching Siren in September 2021. "I'm ALL IN."
www.bizjournals.com/sanfrancisco...

Nicole Paulk is fending off breast cancer while raising money for her cancer-fighting S.F. startup - San Francisco Business Times

This S.F. founder and CEO is fighting cancer personally and professionally.

www.bizjournals.com

Ron Leuty @rleutybiotech.bsky.social · 2d

Kardigan's got late-stage heart drugs, an experienced leadership team and some big crossover investors and VCs who have put in a half-billion dollars. Is an IPO on the horizon?
www.bizjournals.com/sanfrancisco...

Peninsula heart drug company raises $254M with hint of IPO on the horizon - San Francisco Business Times

Here's why this heart drug startup could be the next biotech IPO candidate.

www.bizjournals.com

Ron Leuty @rleutybiotech.bsky.social · 2d

Size does matter: The good, bad and ugly numbers from Peninsula R&D/life sciences leasing www.bizjournals.com/sanfrancisco...

There's interest in Peninsula biotech space, but only the small spaces so far - San Francisco Business Times

Look who's swallowing small bites of Peninsula’s all-too-ample biotech space.

www.bizjournals.com

Ron Leuty @rleutybiotech.bsky.social · 3d

Allergy-focused startup Excellergy scores $70 million
www.bizjournals.com/sanfrancisco...

Aiming for a new way to control allergies, Excellergy raises $70 million to 'challenge for market leadership' - San Francisco Business Times

THis startup just raised $70 million to test its novel approach to allergies.

www.bizjournals.com

Ron Leuty @rleutybiotech.bsky.social · 6d

Elon Musk's Neuralink leases entire South San Francisco building - San Francisco Business Times www.bizjournals.com/sanfrancisco...

Elon Musk's Neuralink leases long-vacant South San Francisco building as xAI shops around - San Francisco Business Times

Elon Musk's brain-computer interface startup Neuralink leases big space on Peninsula.

www.bizjournals.com

Ron Leuty @rleutybiotech.bsky.social · 7d

Akero Therapeutics rides drug for fatty liver disease to $5.2B deal with Novo Nordisk
www.bizjournals.com/sanfrancisco...

Akero Therapeutics rides drug for fatty liver disease to $5.2B deal with Novo Nordisk - San Francisco Business Times

Akero Therapeutics' drug for fatty liver disease ignited interest in the space, and now it has cashed in.

www.bizjournals.com

Ron Leuty @rleutybiotech.bsky.social · 7d

Rebalanced psychedelic drug — backed by OpenAI's Sam Altman and founders of Figma and Coinbase — looks to launch clinical trial in generalized anxiety disorder www.bizjournals.com/sanfrancisco...

Can MDMA help psychiatric disorders? Sam Altman and founders of Coinbase and Figma are betting on it - San Francisco Business Times

Can a safer form of ecstasy help the millions of Americans who struggle with anxiety? A clinical trial backed by famous Silicon Valley tech founders will find out.

www.bizjournals.com

Ron Leuty @rleutybiotech.bsky.social · 8d

One doctor calls new IPO candidate BillionToOne's prenatal test (it also has a cancer test) "a product that changes the way we do medicine" www.bizjournals.com/sanfrancisco...

BillionToOne files for IPO with a special offering for a biotech: Actual revenue - San Francisco Business Times

Behind the IPO and ambitions of diagnostics company BillionToOne.

www.bizjournals.com

Ron Leuty @rleutybiotech.bsky.social · 8d

Can a Peninsula biotech company eliminate a potential source of Alzheimer's by taking out common mouth bacteria?
www.bizjournals.com/sanfrancisco...

2

Ron Leuty @rleutybiotech.bsky.social · 9d

Orca Bio adds to list of Bay Area biotechs in line for FDA drug-approval decisions
www.bizjournals.com/sanfrancisco...

Months after CEO change, Peninsula biotech lines up FDA decision for novel cancer therapy - San Francisco Business Times

A Bay Area biotech company is on the cusp of a potential breakthrough in blood cancer treatment, with regulators set to make a crucial decision.

www.bizjournals.com

Ron Leuty @rleutybiotech.bsky.social · 9d

AIgen Bio's AI and CRISPR tech secures deal with AstraZeneca - San Francisco Business Times www.bizjournals.com/sanfrancisco...

S.F. biotech focused on AI and CRISPR lands potential half-billion-dollar deal with AstraZeneca - San Francisco Business Times

A small S.F. biotech with ties to Nobel Prize-winning research has caught the attention of a pharmaceutical giant, resulting in a deal potentially worth hundreds of millions of dollars.

www.bizjournals.com

Ron Leuty @rleutybiotech.bsky.social · 9d

Schizophrenia-focused MapLight seeks $250M IPO
www.bizjournals.com/sanfrancisco...

MapLight IPO seeks to raise more than $250 million in rare Bay Area biotech debut - San Francisco Business Times

No life-sciences company from the Bay Area has gone public since February, but that hasn't stopped MapLight from aiming high.

www.bizjournals.com

Ron Leuty @rleutybiotech.bsky.social · 10d

Meet the latest Nobel Prize winner with Bay Area ties …
www.bizjournals.com/sanfrancisco...

Peninsula biotech founder wins Nobel Prize for immune system discoveries - San Francisco Business Times

Peninsula biotech founder wins Nobel Prize for immune system discoveries.

www.bizjournals.com

1

Ron Leuty @rleutybiotech.bsky.social · 10d

'This isn't a dress rehearsal': Corcept Therapeutics makes big push into cancer, ALS and more - San Francisco Business Times www.bizjournals.com/sanfrancisco...

'This isn't a dress rehearsal': Why the coming months could be big for a Peninsula drug company that has survived decades - San Francisco Business Times

'This isn't a dress rehearsal': Why the coming months could be big for a Peninsula drug company

www.bizjournals.com

Ron Leuty @rleutybiotech.bsky.social · 10d

How biotechs are raising funding during 'mass extinction event' - San Francisco Business Times www.bizjournals.com/sanfrancisco...

How these biotech companies raised millions during a 'mass extinction event' - San Francisco Business Times

In biotech 'mass extinction event,' these companies raised millions. Where'd they turn for cash?

www.bizjournals.com

Reposted by Ron Leuty

AAUP @aaup.org · 13d

UC’s Academic Council calls on the Office of the President & the UC Board of Regents to unequivocally reject governmental demands that compromise institutional autonomy and #academicfreedom.

This is the way.

#DefendHigherEd

Brian Soucek @brsoucek.bsky.social · 13d

Strong statement today from UC's Academic Senate:

2 65 190

Ron Leuty @rleutybiotech.bsky.social · 13d

Here's the whopping amount you could land from 23andMe's data breach settlement
www.bizjournals.com/sanfrancisco...

Here's how much the 23andMe data breach settlement could pay you - San Francisco Business Times

The 23andMe data breach settlement will pay out $30 million to $50 million in total — Here's how much you could get.

www.bizjournals.com

Ron Leuty @rleutybiotech.bsky.social · 14d

Cartography Biosciences raises $67M from Pfizer, Amgen and others for T-cell engagers against cancers - San Francisco Business Times www.bizjournals.com/sanfrancisco...

Cartography Bio maps out cancer drug plan with $67 million from Pfizer, Amgen venture units and more - San Francisco Business Times

How a cancer-focused biotech with fresh $67M is mapping its future

www.bizjournals.com

Ron Leuty @rleutybiotech.bsky.social · 14d

Inside Roche's potential $3.5 billion deal for fatty liver disease drug maker 89bio www.bizjournals.com/sanfrancisco...

How a small Bay Area drug company landed a potential $3.5 billion acquisition despite pharma funding drought - San Francisco Business Times

Let's make a deal: How a Bay Area drug company landed a potential $3.5 billion deal with Genentech parent Roche

www.bizjournals.com

Ron Leuty @rleutybiotech.bsky.social · 14d

89bio played a potential $3.5 billion poker game with Roche -- and both companies could win
www.bizjournals.com/sanfrancisco...

How a small Bay Area drug company landed a potential $3.5 billion acquisition despite pharma funding drought - San Francisco Business Times

Let's make a deal: How a Bay Area drug company landed a potential $3.5 billion deal with Genentech parent Roche

www.bizjournals.com

Ron Leuty @rleutybiotech.bsky.social · 15d

UC Berkeley spinout Ansa Biotechnologies raises $54 million, talks about a biomanufacturing revolution - San Francisco Business Times
www.bizjournals.com/sanfrancisco...

Promising a biomanufacturing revolution, UC Berkeley spinout focused on DNA raises $54M - San Francisco Business Times

Get your DNA on time or its free, UC Berkeley spinout's CEO promises customers as he raises more than $50 million.

www.bizjournals.com

1 1